Impact on Opioid Use of Bundling Medication-assisted Treatment With mHealth

Not Applicable

Completed

• Conditions: Opioid Use Disorder
• Interventions: Other: MAT; Behavioral: MAT + A-CHESS

• Registration Number: NCT02712034
• Lead Sponsor: University of Wisconsin, Madison

Brief Summary

The primary aim of this study is to measure and explain the impact on long-term opioid use when medication-assisted treatment (MAT) is bundled with an evidence-based mobile-health system (A-CHESS).

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2016-03-14
• Study First Submitted QC: 2016-03-16
• Study First Posted: 2016-03-17
• Study Start: 2016-04-21
• Status Verified: 2020-04
• Primary Completion: 2020-04-08
• Study Completion: 2020-04-08
• Last Update Submitted: 2020-04-10
• Last Update Posted: 2020-04-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 417

Inclusion Criteria

1. are 18+ years old;
2. meet criteria for opioid use disorders of at least moderate severity (4 or 5 DSM-V criteria);
3. Are currently taking medication-assisted treatment (MAT) as part of their standard clinical care;
4. have no acute medical problem requiring immediate inpatient treatment;
5. have no history of psychotic disorders, though those with other co-morbid psychopathology (mood disorders, anxiety, other substance use disorders) will be eligible;
6. are willing to participate in a randomized clinical trial;
7. provide the name, verified telephone number, and address of at least 2 contacts willing to help locate the patient, if necessary, during follow-up;
8. are able to read and write in English;
9. are not pregnant;
10. are willing to share health-related data with primary care clinicians; and
11. are, at study intake, abstinent from opioids for at least 1 week and no longer than 2 months, except for medications used to treat the disorder (e.g., methadone).

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Medication-assisted treatment (MAT)	MAT	Patients will receive standard medication-assisted treatment (MAT) as prescribed by their health care provider.
MAT + A-CHESS	MAT + A-CHESS	Patients in the MAT + A-CHESS arm will receive MAT as described plus the A-CHESS recovery support system via a smartphone.

Primary Outcome Measures

Name	Time	Method
Opioid use	24 months	Detect the difference in illicit opioid use between patients who have MAT + A-CHESS vs. MAT alone.

Trial Locations

Locations (1)

Access Community Health Centers; 🇺🇸 Madison, Wisconsin, United States